Keyword Connections

chronic lymphocytic leukemia

Journals

6

1 Scientific reports

2 Anticancer research

3 Frontiers in oncology

4 Leukemia research

5 expert opinion on biological therapy

6 Leukemia & lymphoma

Research Groups

0

No Research Group Connected

Bibliographies

45

1 Minimal Residual Disease in Chronic Lymphocytic Leukemia: A New Goal?

2 Optimisation of robust singleplex and multiplex droplet digital PCR assays for high confidence mutation detection in circulating tumour DNA.

3 The up-to-date role of biologics for the treatment of chronic lymphocytic leukemia.

4 fludarabine induces apoptosis in chronic lymphocytic leukemia - the role of p53, bcl-2, bax, mcl-1, and bag-1 proteins

5 circulating proangiogenic cytokines and angiogenesis inhibitor endostatin in untreated patients with chronic lymphocytic leukemia

6 recurrent malignant melanoma presenting as isolated pleural metastases in a patient with chronic lymphocytic leukemia

7 bcr signaling inhibitors: an overview of toxicities associated with ibrutinib and idelalisib in patients with chronic lymphocytic leukemia

8 deregulated levels of the nf-κb1, nf-κb2, and rel genes in ukrainian patients with leukemia and lymphoma in the post-chernobyl period

9 smudge cells in peripheral blood smears did not differentiate chronic lymphocytic leukemia from other b-cell chronic lymphoprolipherative diseases sombras nucleares no esfregaço do sangue periférico não diferenciam a leucemia linfocítica crônica das outras doenças linfoproliferativas b crônicas

10 ibrutinib as a bridge to transplant in high-risk chronic lymphocytic leukemia: a case report and review of the literature

11 detection of paroxysmal nocturnal hemoglobinuria-phenotype in patients with chronic lymphocytic leukemia and multiple myeloma

12 using murine models to investigate tumor–lymphoid interactions: spotlight on chronic lymphocytic leukemia and angioimmunoblastic t-cell lymphoma

13 Overexpression of Galectin-3 in Chronic Lymphocytic Leukemia Is Associated With 17p Deletion: A Short Report.

14 Identification of new phosphorylation sites of CD23 in B-cells of patients with chronic lymphocytic leukemia.

15 Altered expression pattern of SLAM family receptors on pathological B cells of patients with chronic lymphocytic leukemia.

16 Characterization of Chronic Lymphocytic Leukemia Immunoglobulin Rearrangements from Partial Read Sequencing.

17 Automated shape-based clustering of 3D immunoglobulin protein structures in chronic lymphocytic leukemia

18 Targeting CD20 in chronic lymphocytic leukemia

19 Targeting CD20 in chronic lymphocytic leukemia

20 Targeting CD20 in chronic lymphocytic leukemia

21 Composite Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma and T-Prolymphocytic Leukemia Presenting with Lymphocytosis, Skin Lesions, and Generalized Lymphadenopathy

22 Paranasal Manifestations of Early Stage Chronic Lymphocytic Leukemia

23 Immunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in chronic lymphocytic leukemia

24 Immunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in chronic lymphocytic leukemia

25 stim1 at the plasma membrane as a new target in progressive chronic lymphocytic leukemia

26 the spectrum of genetic defects in chronic lymphocytic leukemia

27 ofatumumab – a valid treatment option for chronic lymphocytic leukemia patients

28 spontaneous retroperitoneal hemorrhage in a patient with prolymphocytic transformation of chronic lymphocytic leukemia

29 improvement of paraneoplastic limbic encephalitis after systemic treatment with rituximab in a patient with b-cell chronic lymphocytic leukemia

30 expression of hla-g in patients with b-cell chronic lymphocytic leukemia (b-cll).

31 aureobasidium pullulans infection in a patient with chronic lymphocytic leukemia

32 altered n-linked glycosylation in follicular lymphoma and chronic lymphocytic leukemia: involvement in pathogenesis and potential therapeutic targeting

33 fe de errores de "evaluación económica de rituximab en combinación con fludarabina y ciclofosfamida en comparación con fludarabina y ciclofosfamida en el tratamiento de la leucemia linfática crónica" erratum to "economic evaluation of rituximab added to fludarabine plus cyclophosphamide versus fludarabine plus cyclophosphamide for the treatment of chronic lymphocytic leukemia"

34 human endogenous retrovirus np9 gene is over expressed in chronic lymphocytic leukemia patients

35 peptide vaccination induces profound changes in the immune system in patients with b-cell chronic lymphocytic leukemia

36 prostatic-like syndrome in a woman with chronic lymphocytic leukemia: sequential kinase inhibitor therapy

37 guidelines for diagnosis and treatment of chronic lymphocytic leukemia

38 bcl-2 and bax interaction in b-lymphocytes of peripheral blood in patients with chronic lymphocytic leukemia

39 new developments in the treatment of chronic lymphocytic leukemia: role of obinutuzumab

40 coexistence of chronic lymphocytic leukemia and myeloproliferative neoplasm

41 Fludarabine combined with cyclophosphamid is highly effective in the treatment of chronic lymphocytic leukemia.

42 Characterization of a New Chronic Lymphocytic Leukemia Cell Line for Mechanistic In Vitro and In Vivo Studies Relevant to Disease

43 Pentostatin, Cyclophosphamide and Rituximab Followed by Alemtuzumab for Relapsed or Refractory Chronic Lymphocytic Leukemia: A Phase 2 Trial of the ECOG-ACRIN Cancer Research Group (E2903)

44 Characterization of a New Chronic Lymphocytic Leukemia Cell Line for Mechanistic In Vitro and In Vivo Studies Relevant to Disease

45 Frontline Therapy for Chronic Lymphocytic Leukemia: The Dilemma Continues